At Apocare Pharma GmbH, the health and well-being of our youngest patients is particularly important to us. Providing medicines that are specifically tailored to the unique medical needs of children is a special task. Children represent a particularly vulnerable patient group whose medical requirements differ significantly from those of adults. It is our key responsibility to develop medicines that are not only safe and effective, but also child-friendly and customisable to provide young patients with the best possible treatment.
Children are not small adults
Pediatric medicines are close to our hearts
Accepting the challenges
The development of paediatric medicines faces unique challenges, including limited clinical data and the need to consider ethical and practical issues. Despite these obstacles, investing in the research and development of paediatric medicines is an important endeavour. Our goal is to provide solutions for a wide range of paediatric diseases. Without specially developed paediatric medicines, young patients are at increased risk of inadequate treatment and potential complications.
Safety and child-friendly formulations: Our priority
The safety of paediatric medicines is at the forefront of our efforts. We attach great importance to offering medicines in child-friendly forms – from liquid formulations to granules – in order to facilitate the intake of medicines and improve treatment compliance.
Accessibility of medicines: A fundamental right
Ensuring the accessibility of paediatric medicines must remain a key concern. We are working on this with our partners in the healthcare sector.